First Study of Nutritional Cognitive Behavioral Therapy for Fatty Liver Disease and Expanded Real-World Evidence Studies for Type 2 Diabetes Follow Promising Primary Endpoint Clinical Trial Data
SAN FRANCISCO--(BUSINESS
Gainers
Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
Better Therapeutics Inc (NASDAQ: BTTX) has announced primary endpoint data from its pivotal trial of BT-001 designed to use digitally delivered cognitive-behavioral therapy (nCBT) to treat type 2 diabetes.
Gainers
Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million.
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.